Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr. Reddy's Laboratories informs about press release
Date: 19-10-2021Dr. Reddy's Laboratories has informed that it enclosed a Press Release dated October 19, 2021 ‘Dr. Reddy's Laboratories announces approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)’.
The above information is a part of company’s filings submitted to BSE.